B. Taylor Thompson MD Director, Medical Intensive Care Unit Dr. Thompson is the Director of the Medical Intensive Care Unit at the Massachusetts General Hospital and a Professor of Medicine at Harvard Medical School.
BiographyDr. Thompson is a California native who joined the Department of Medicine and the Pulmonary and Critical Care Unit at MGH in 1985. He directed the Pulmonary and Critical Care Fellowship training program until 1990 and the Medical Intensive Care Unit until 2011. He now the Director of Critical Care Translational Research in the Pulmonary and Critical Care Unit. His current patient care activities are focused solely on caring for critically ill patients and their families. He has been actively involved in teaching at Harvard Medical School where he is a Professor of Medicine. He has been an active clinical investigator for over 25 years. His primary research and academic interests involve managing clinical trials for patients with the Acute Respiratory Distress Syndrome (ARDS) or severe sepsis, investigating the molecular epidemiology of ARDS and sepsis, and developing and testing computerized bedside decision support tools.
ResearchDr. Thompson is the Medical Director of the NHLBI-funded ARDS Network Clinical Coordinating Center where he coordinates randomized controlled trials for patients with ARDS. Dr Thompson is also the Co-Principal Investigator of an international trial investigating drotrecogin-alfa (activated) versus placebo for the treatment of persistent septic shock (the PROWESS-SHOCK trial). In collaboration with Drs' Christiani and Bajwa at MGH, Dr. Thompson is exploring the molecular epidemiology of ARDS susceptibility and ARDS and sepsis clinical outcomes. Dr Thompson is working with Dr. Michael Matthay at UCSF on the design and implementation of a Phase II trial of mesenchymal stem cells for the treatment of ALI and with Augustine Choi at the Brigham and Women's Hospital on the design and implementation of a clinical trial of inhaled carbon monoxide as a potential therapeutic agent for ARDS.
Dr. Thompson is the author or co-author of over 150 peer reviewed publications, reviews, and book chapters.
Massachusetts General Hospital investigators collaborate with clinical staff to generate new knowledge and discuss innovations at the First Annual Critical Care Research Retreat.